<!-- not likely{{confused|sulfisoxazole}} -->
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 408892547
| IUPAC_name = 4-amino-''N''-pyrimidin- 2-yl-benzenesulfonamide
| image = Sulfadiazine-2D-skeletal.png
| width = 250
| image2 = Sulfadiazine-3D-vdW.png
| width2 = 250
<!--Clinical data-->
| tradename =  
| class = [[Antibiotic]] ([[Sulfonamide (medicine)|sulfonamide]])<ref name=AHFS2016/>

| Drugs.com = {{drugs.com|monograph|sulfadiazine}}
| MedlinePlus = a682130
| pregnancy_US = C<ref name="pregnancy">{{cite web|title=Sulfadiazine Use During Pregnancy {{!}} Drugs.com|url=https://www.drugs.com/pregnancy/sulfadiazine.html|website=www.drugs.com|accessdate=28 June 2017|deadurl=no|archiveurl=https://web.archive.org/web/20161220222638/https://www.drugs.com/pregnancy/sulfadiazine.html|archivedate=20 December 2016|df=}}</ref>
| legal_status = Rx only
| routes_of_administration = Topical cream, by mouth
<!--Pharmacokinetic data-->
| bioavailability = ?
| protein_bound = 38-48%<ref name="drugs.com">{{cite web|title=Sulfadiazine Monograph for Professionals {{!}} Drugs.com|url=https://www.drugs.com/monograph/sulfadiazine.html|website=www.drugs.com|accessdate=28 June 2017|5=|deadurl=no|archiveurl=https://web.archive.org/web/20161220223703/https://www.drugs.com/monograph/sulfadiazine.html|archivedate=20 December 2016|df=}}</ref>
| metabolism = [[Liver]] ([[acetylation]])<ref name = "drugs.com" />
| elimination_half-life = 7-17 hours <ref name = "drugs.com" />
| excretion = Urine <ref name = "drugs.com" />
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 68-35-9
| ATC_prefix = J01
| ATC_suffix = EC02
| ATC_supplemental = {{ATCvet|J01|EQ10}}
| PubChem = 5215
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00359
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 5026
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 0N7609K889
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00587
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 439
<!--Chemical data-->
| C=10 | H=10 | N=4 | O=2 | S=1
| molecular_weight = 250.278 g/mol
| melting_point     = 252
| melting_high      = 256
}}

<!-- Definition and medical uses -->
'''Sulfadiazine''' is an [[antibiotic]].<ref name=AHFS2016>{{cite web|title=Sulfadiazine|url=https://www.drugs.com/monograph/sulfadiazine.html|publisher=The American Society of Health-System Pharmacists|accessdate=8 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161220223703/https://www.drugs.com/monograph/sulfadiazine.html|archivedate=20 December 2016|df=}}</ref> Used together with [[pyrimethamine]], it is the treatment of choice for [[toxoplasmosis]].<ref name=WHO2008>{{cite book|title=WHO Model Formulary 2008|date=2009|publisher=World Health Organization|isbn=9789241547659|pages=126, 205|url=http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|accessdate=8 December 2016|deadurl=no|archiveurl=https://web.archive.org/web/20161213060118/http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf|archivedate=13 December 2016|df=}}</ref> It is a second line treatment for [[otitis media]], prevention of [[rheumatic fever]], [[chancroid]], [[chlamydia]] and infections by ''[[Haemophilus influenzae]]''.<ref name=AHFS2016/> It is taken by mouth.<ref name=AHFS2016/>

<!-- Side effects and mechanism -->
Common side effects include nausea, diarrhea, headache, fever, rash, depression, and [[pancreatitis]].<ref name=AHFS2016/> It should not be used in people who have severe liver problems, kidney problems, or [[porphyria]].<ref name=WHO2008/> If used during [[pregnancy]] it may increase the risk of [[kernicterus]] in the baby.<ref name=AHFS2016/> While the company that makes it does not recommend use during [[breastfeeding]], use is believed to be safe if the baby is otherwise healthy.<ref name=pregnancy/> It is in the [[Sulfonamide (medicine)|sulfonamide]] class of medications.<ref name=AHFS2016/>

<!-- Society and culture -->
Sulfadiazine was approved for medical use in the United States in 1941.<ref name=AHFS2016/> It is on the [[World Health Organization's List of Essential Medicines]], the most effective and safe medicines needed in a [[health system]].<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref> Sulfadiazine is available as a [[generic medication]].<ref name=AHFS2016/> The wholesale cost in the [[developing world]] is about 2.70 to 7.32 USD a month.<ref name=ERC2014>{{cite web|title=Sulfadiazine|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=SUL500T&s_year=2014&year=2014&str=500%20mg&desc=Sulfadiazine&pack=new&frm=TAB-CAP&rte=PO&class_code2=06%2E5%2E4%2E&supplement=&class_name=%2806%2E5%2E4%2E%29Anti-pneumocystosis%20and%20antitoxoplasmosis%20medicines%3Cbr%3E|website=International Drug Price Indicator Guide|accessdate=8 December 2016}}</ref> In the United States treatment costs more than 200 USD a month.<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=104}}</ref>

==Medical uses==
It eliminates [[bacteria]] that cause infections by stopping the production of [[folic acid|folate]] inside the bacterial cell, and is commonly used to treat [[urinary tract infection]]s, and burns.

In combination, sulfadiazine and [[pyrimethamine]], can be used to treat [[toxoplasmosis]], a disease caused by ''[[Toxoplasma gondii]]''.

==Mechanism of action==
Sulfadiazine works by inhibiting the enzyme [[Dihydropteroate synthase|dihydropteroate synthetase]]. In combination with [[pyrimethamine]] (a [[dihydrofolate reductase]] inhibitor), sulfadiazine is used to treat active [[toxoplasmosis]].

==Side effects==
Side effects reported for sulfadiazine include: [[nausea]], [[upset stomach]], [[loss of appetite]], and [[dizziness]].

== Brand names ==
Lantrisul; Neotrizine; Sulfa-Triple #2; Sulfadiazine; Sulfaloid; Sulfonamides Duplex; Sulfose; Terfonyl; Triple Sulfa; Triple Sulfas; Triple Sulfoid

==See also==
* [[Silver sulfadiazine]]

== References ==
{{Reflist}}

{{Sulfonamides and trimethoprim}}
{{Antiprotozoal agent}}

[[Category:Aromatic amines]]
[[Category:Pyrimidines]]
[[Category:World Health Organization essential medicines]]
[[Category:Sulfonamide antibiotics]]
[[Category:Anilines]]
[[Category:RTT]]